Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohit M Mahatma

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Bone and Joint Surgery. American Volume|October 20, 2020
Influence of Femoral Component Design on Proximal Femoral Bone Mass After Total Hip Replacement: A Randomized Controlled TrialPablo A Slullitel, Mohit M Mahatma, Mohsen Farzi, et al.
The Journal of Arthroplasty|October 15, 2021
Does a Monoblock Acetabular Component With a Ceramic Liner Cause More Pelvic Bone Loss Than a Conventional Modular Cementless Acetabular Component? A 2-Year Randomized Clinical TrialDaniel Fischman, Mohit M Mahatma, Pablo Slullitel, et al.
The Lancet. Rheumatology|January 27, 2024
Effect of denosumab on osteolytic lesion activity after total hip arthroplasty: a single-centre, randomised, double-blind, placebo-controlled, proof of concept trialMohit M Mahatma, Raveen L Jayasuriya, David Hughes, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Bone and Joint Surgery. American Volume|October 20, 2020
Influence of Femoral Component Design on Proximal Femoral Bone Mass After Total Hip Replacement: A Randomized Controlled TrialPablo A Slullitel, Mohit M Mahatma, Mohsen Farzi, et al.
The Journal of Arthroplasty|October 15, 2021
Does a Monoblock Acetabular Component With a Ceramic Liner Cause More Pelvic Bone Loss Than a Conventional Modular Cementless Acetabular Component? A 2-Year Randomized Clinical TrialDaniel Fischman, Mohit M Mahatma, Pablo Slullitel, et al.
The Lancet. Rheumatology|January 27, 2024
Effect of denosumab on osteolytic lesion activity after total hip arthroplasty: a single-centre, randomised, double-blind, placebo-controlled, proof of concept trialMohit M Mahatma, Raveen L Jayasuriya, David Hughes, et al.
Pageof 1